Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI ....
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 8th August 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025 (Q1 FY26). This is a routine regulatory disclosure under SEBI Listing Regulations. The trading window for dealing in the company's shares, which closed on 1st July 2025, will remain closed until 48 hours after the results are declared on 8th August.
No immediate impact on shareholders — this is a standard advance notice ahead of the quarterly results announcement on 8th August 2025, which will be the actual catalyst for any stock movement.